Phase 2 Study Evaluating the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral AZ-3102 in Patients With GM2 Gangliosidosis or Niemann-Pick Type C Disease
Clinical trial NCT05758922 · COMPLETED
Trial details
- NCT number
- NCT05758922
- Sponsor
- Azafaros B.V.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-24
- Primary completion
- 2024-04-19
- Enrollment
- 13
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.